Published in Hepatitis Weekly, February 5th, 2001
While interferon is an effective treatment for many patients with chronic hepatitis C, others who take it will not respond to therapy at all, or will relapse with signs of transient biochemical response. This second group, the transient...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.